Prevalence of hepatic dysfunction in children with dengue fever
Siddappa F.D.1, Varsha Lakshman2, Madhu P.K.3
1Dr. Siddappa F.D., 2Dr.
Varsha Lakshman, 3Dr. Madhu P.K, all authors are affiliated with Department of Paediatrics, Karnataka Institute
of Medical Sciences, Hubli, Karnataka, India.
Corresponding Author: Dr. Madhu P.K., Department of Paediatrics, Karnataka Institute
of Medical Sciences,
Hubli, Karnataka, India, E-mail: drmadhupk@gmail.com
Abstract
Background:Dengue
is one disease entity with different clinical presentations and often with
unpredictable clinical evolution and outcome. The degree of liver dysfunction
in children with dengue infection varies from mild injury with elevation of
transaminases to severe injury with jaundice and liver cell failure. This study
was undertaken to find the prevalence of hepatic dysfunction in children
admitted with Dengue fever.Methods:All
children with serologically (dengue NS1 antigen detection and/or dengue IgM Mac
ELISA) confirmed dengue fever aged between 2 months and 12 years were included
in the study. Children with other etiologies of hepatitis were excluded. Liver
function tests including bilirubin, transaminases and prothrombin time (PT) were
done. Prevalence and severity of hepatic dysfunction were statistically
analysed and compared between different categories of dengue fever severity. Results:Hepatic dysfunction was present
in 35 (67.30%) of the 52 children included in the study.About 85.71% of the
children with dengue fever in the age group of 2 months to 1 year had hepatic
dysfunction. In children with severe dengue, 83.3% had hepatic dysfunction.Raised
liver enzymes in 32(61.53%), hepatomegaly in 21(40.48%), INR≥1.5 in 8(15.38%)
and jaundice in 1(1.92%) children were the manifestations. None of the patients
had acute hepatic failure or hepatic encephalopathy.Association of hepatomegaly
with increasing disease severity was statistically significant (p = 0.0262). Hepatic
dysfunction was present in 83.33% and 87.5% of children with abdominal pain and
clinical fluid accumulation respectively. Of the 32 patients (61.53%) with
elevated transaminases, 18 (51.42%) had elevated levels of AST alone, 40% had
elevation of AST and ALT both. Conclusions:
The prevalence of hepatic dysfunction among children with dengue fever is
67.30%, more commonly observed in severe forms of dengue. Spectrum of hepatic
involvement ranges from raised liver enzymes without jaundice to clinically
evident jaundice. Hepatic dysfunction is commonly observed in children with
abdominal pain and clinical fluid accumulation.
Keywords:
Children, Dengue fever, Liver functions, Jaundice, Hepatitis, Transaminases
Author Corrected: 14th January 2019 Accepted for Publication: 17th January 2019
Introduction
Dengue is a major public-health concern
throughout tropical and sub-tropical regions of the world. It is the most
rapidly spreading mosquito-borne viral disease, with a 30-fold increase in
global incidence over the past 50 years. Although the full global burden of the
disease is still uncertain, the patterns are alarming for both human health and
the economy. While dengue is a global concern, with a steady increase in the
number of countries reporting the disease, currently close to 75% of the global
population exposed to dengue are in the Asia-Pacific region[1]. An estimated 50
million dengue infections occur annually and approximately 2.5 billion people
live in dengue endemic countries [2].Dengue constitutes a major cause of
paediatric morbidity and mortality in South East Asian countries. In children,
risk of death during secondary attack is nearly 15 folds higher than that of adults
[3].
In humans, dengue infection causes a spectrum
of illness ranging from relatively mild, non-specific viral syndrome to severe
haemorrhagic disease and death. Expert consensus groups in Latin America,
South-East Asia, and at WHO headquarters in Geneva, Switzerland in 2008 agreed
that: “dengue is one disease entity with different clinical presentations and
often with unpredictable clinical evolution and outcome”[2]. Unusual
manifestations of dengue involving liver, heart and central nervous system have
been reported. The degree of liver dysfunction in children with dengue
infection varies from mild injury with elevation of transaminases to severe
injury with jaundice and liver cell failure. Mechanisms of liver injury in
dengue may be due to direct effects of the virus or host immune response on
liver cells, circulatory compromise, metabolic acidosis and/or hypoxia caused
by hypotension or localized vascular leakage inside the liver [4,5].
Pathological findings on liver biopsy includes hepatocellular necrosis, fatty
change, kupffer cell hyperplasia and inflammatory cell infiltration [6,7].
The incidence of hepatic dysfunction is more
in dengue shock syndrome and Dengue hemorrhagic fever [4,8]. Rising of
aminotransferase level occurs in the acute phase of the disease and elevated
liver enzymes is an early marker of dengue infection [5]. Aminotransferase
levels are also useful in predicting the occurrence of hepatic dysfunction and
spontaneous bleeding [4]. In recent studies dengue infection was the most
important cause of acute hepatic failure in children contributing 18.5% to
34.3% of the cases [4,9].
In developing country like India with huge
population and poor health care facilities, it is important to know the
prevalence of liver injury in children with dengue, so as to suspect and manage
complications associated with liver injury despite lack of appropriate
laboratory investigations.This study was undertaken to know the prevalence,
severity and spectrum of hepatic dysfunction in serologically confirmed cases
of dengue fever in children admitted to a tertiary care hospital in north
Karnataka.
Methods
Place of study: Department
of Paediatrics, Karnataka Institute of Medical Sciences, Hubli, Karnataka
Type of study: Prospectiveobservational studyconducted from
December 2016 to November 2017.
Sampling methods: All the clinically suspected cases of dengue
fever aged between 2 months and 12 years as per the World Health Organization (WHO)
guidelines, admitted during the study period were screened for dengue infection
by Dengue NS1 antigen detection and/or positive dengue IgM Mac ELISA [2].
Inclusion criteria: All
serologically confirmed cases of dengue fever (by dengue NS1 antigen detection
and/or positive dengue IgM Mac ELISA) were included in the study.
Exclusion criteria: Drug
induced hepatitis and infective etiologies of hepatitis like malaria, enteric
fever, hepatitis A and hepatitis B were excluded by history, examination and/or
investigations.
Sample Collection:
Informed consent was obtained from parents or guardians of the child included
in the study. Detailed history was obtained and clinical examination was
performed. Findings were entered in a predesigned proforma. Venous blood (5ml
each) of all the children included in the study was collected in plain bottles,
centrifuged and serum was separated. Total serum bilirubin (TSB), direct serum
bilirubin, indirect serum bilirubin, alanine transaminase (ALT), aspartate
transaminase (AST), alkaline phosphatase (ALP), total proteins, serum albumin
were measured using Trans Asian Biochemicals ERBA XL-300 fully computerised
auto-analyser by advanced calorimetric methods. Prothrombin time
(PT)/international normalized ratio (INR) was measured by Trans Asian ERBA
Coagulometer using Liquiplastin as a reagent on 2ml of blood collected in
citrate tube to prevent the clotting process. Normal age specific ranges of
biochemical indices of liver functionsand liver spanwere used to identify derangements
[10,11]. (Appendix 1)
Appendix-1: Age Specific range of biochemical
indices and liver span.
Parameters |
Age range |
Normal range |
Total bilirubin |
1month-adults |
<1.2mg/dl |
Direct bilirubin |
1month-adults |
<0.2mg/dl |
Total protein |
15days-1yr |
5.1-7.3g/dl |
1-2yr |
5.6-7.5g/dl |
|
3-16yr |
6.0-8.0g/dl |
|
Serum albumin |
15days-1yr |
2.2-4.8g/dl |
1-2yr |
3.6-5.2g/dl |
|
3-16yr |
3.6-5.2g/dl |
|
Alanine aminotransferase |
1-3yr |
13-45U/L |
4-6yr |
10-25U/L |
|
7-9yr |
10-35U/L |
|
10-11yr |
10-35U/L |
|
Aspartate aminotransferase |
0-10days |
47-150U/L |
10days-24months |
9-80U/L |
|
>24months
female |
13-35U/L |
|
>24months
male |
15-40/L |
|
Normal liver span |
Less
than 1 year |
4–5
cm |
1–5
year |
5–7
cm |
|
5–12
years |
7–9
cm |
|
More
than 12 years |
9–12
cm |
Scoring systems and definitions:Severity of dengue fever was classified as 1) dengue
without warning signs, 2) dengue with warning signs and 3) severe dengue as per
WHO [2].
The following definitions were used for each of the warning signs:
Abdominal pain: abdominal tenderness and continuous pain, on some occasions
diffuse. Persistent vomiting: more than three episodes of vomiting in 12 hours,
preventing adequate oral hydration. Clinical accumulation of liquids: pleural
effusion and ascites diagnosed clinically, confirmed with imaging techniques.
Mucosal bleeding: bleeding gums or conjunctiva, epistaxis, vaginal bleeding,
bleeding from digestive, respiratory or urinary system (kidneys); mucosa
defined as respiratory, vaginal, digestive, conjunctival and urinary tract
mucosa. Lethargy: evaluated as an alteration of consciousness with a Glasgow
score less than 15. Irritability: irritability or restlessness [12].
Liver dysfunction was considered to be present if any one of the
findings like 1) elevated AST and/or ALT levels more than twice the upper limit
of normal (ULN) for age with or without hepatomegaly, 2)jaundice or 3) INR ≥
1.5 was present.
Based on elevation of liver enzymes (AST and/or ALT), liver dysfunction
was graded as 1) Liver function
impairment was defined as an increase in AST and/or ALT level of at least
twice the upper limit of normal, 2) Hepatitis
was defined as an AST and/or ALT level at least four times higher than the
upper limit of normal and 3) Severe
hepatitis was defined as an AST and/or ALT level of at least 10 times
higher than the upper limit of normal for age [6].
Statical Methods: Demographic, clinical and biochemical
results were tabulated in Microsoft Excel sheet and statistical analysis was
done using SPSS 20 software. Categorical data were presented as frequency
percentage (%) and continuous data were presented as mean and standard
deviation (SD) or median and interquartile range. Categorical variables between
the groups were compared using chi- square test and continuous variables were
analysed using t-test for comparison of two means or one way ANOVA for multiple
means. Appropriate statistical methods were employed for non-parametric data.
Results
A total of 103 children admitted with
suspected dengue fever were screened for dengue NS1 antigen detection or
positive dengue IgM by Mac ELISA. NS1 antigen and/or dengue Ig M was positive
in 53 children, and serologically confirmed with dengue infection. One case was
excluded due to coinfection with malaria. A total of 52 children were further
analysed for presence of hepatic dysfunction. According to WHO classification
of dengue fever severity, 26 (50%) belonged to dengue without warning signs,
20(38.46%) belonged to dengue with warning signs and 6(11.54%) belonged to severe
dengue. Males were 34 (65.38%) and females 18 (34.61%) with a male to female
ratio of 1.7:1. The mean age of occurrence of dengue fever was 6.36±3.9 years.
There were 7 (13.46%) children in the age group of 2 months to 12 months, 16
(30.77%) each in the age groups of 1- 5 years and 6- 10 years and 13 (25%)
children were more than 11 years old(Figure 1).
Figure-1:
Dengue severity and proportion of children with hepatic dysfunction
Fever was the chief complaint presents in all
the cases, followed by vomiting in 32(61.53%), abdominal pain or tendernessin 18(34.61%)
and myalgia in 12(23.07%). Clinical signs included flushing in 26 (50%),
hepatomegaly in 21(40.38%), rashes/petechiae in 11(21.15%), pedal edema in
3(5.77%) and icterus in 1(1.92%). Clinical fluid accumulation was noticed in
8(15.38%) and mucosal bleeding in 16(30.76%) children. Persistent vomiting
defined as more than three episodes of vomiting in 12 hours, preventing
adequate oral hydration was present in 14(26.92%) children (Table 1).
Table-1: Symptoms and signs of all Dengue
cases (n=52)
Symptoms and signs |
Total |
Percentage (%) |
Fever |
52 |
100 |
Vomiting |
32 |
61.53 |
Flushing |
26 |
50 |
Hepatomegaly |
21 |
40.38 |
Abdominal
pain or tenderness |
18 |
34.61 |
Mucosal
bleeding Malena
and/or Hematemesis and/or Epistaxis |
16 |
30.76 |
Persistent
Vomiting |
14 |
26.92 |
Myalgia |
12 |
23.07 |
Rashes/
Petechiae |
11 |
21.15 |
Facial
puffiness |
9 |
17.30 |
Clinical
fluid accumulation (Ascites
and/or Pleural
effusion) |
8 |
15.38 |
Lethargy/Restlessness |
8 |
15.38 |
Shock |
4 |
7.69 |
Convulsions |
4 |
7.69 |
Pedal
edema |
3 |
5.77 |
Icterus |
1 |
1.92 |
Of the 52 cases, hepatic dysfunction was
present in 35 (67.30%) patients. Most common criteria met in the study to
define hepatic dysfunction was elevated liver enzymes 32 (61.53%), followed by
hepatomegaly 21 (40.48%), INR≥1.5 in 8 (15.38%) children. Jaundice was present
in 1 (1.92%) child. None of the patients had acute hepatic failure or hepatic
encephalopathy. Hepatomegaly was present in 21(40.38%) cases. All patients with
severe dengue had hepatomegaly. Whereas 68.75% of dengue with warning signs and
35.71% of dengue without warning signs patients had hepatomegaly. This
association of hepatomegaly with disease severity was statistically significant
(p = 0.0262). (Table 2)
Table-2: Hepatic dysfunctions (n=52)
Hepatic dysfunctions |
Number |
Percentage (%) |
Elevated liver enzymes (>2 times) |
32 |
61.53 |
Hepatomegaly |
21 |
40.38 |
INR≥ 1.5 |
8 |
15.38 |
Jaundice |
1 |
1.92 |
Hepatic dysfunction was observed in 64.70% of
males and 72.22% of females. Among Children aged 2 months to 12 months, 85.71% had hepatic dysfunction. Prevalence
of hepatic involvement was highest among children with severe dengue (83.3%) followed by dengue with warning signs
(80%). On analysis of sex, age and severity of dengue for development of
hepatic dysfunction, the values were found to be not statisticallysignificant. Hepatic
dysfunction was present in 83.33% and 87.5% of children with abdominal pain and
clinical fluid accumulation respectively. But this observation was not
statistically significant. (Table 3)
Table-3: Risk factor for hepatic dysfunction
Risk factors |
No. of children (n=52) |
Hepatic dysfunction present (n=35) |
P value (chi square value) |
Sex |
|||
Male |
34 |
22
(64.70%) |
0.5831
(0.3022) |
Female |
18 |
13
(72.22%) |
|
Age |
|||
2-12 months |
7 |
6 (85.71%) |
0.4431
(2.6812) |
1-5yrs |
16 |
10 (62.5%) |
|
6-10yrs |
16 |
9 (56.25%) |
|
>11yrs |
13 |
10 (76.925) |
|
Dengue severity |
|||
Dengue without warning signs |
26 |
14
(53.84%) |
0.5601
(1.1592) |
Dengue with warning signs |
20 |
16
(80.0%) |
|
Severe dengue |
6 |
5
(83.3%) |
|
Warning signs |
|||
Abdominal pain or tenderness |
18 |
15(83.33%) |
0.1383
(2.1957) |
Mucosal
bleeding |
16 |
9
(56.25%) |
0.4162
(0.6609) |
Persistent Vomiting |
14 |
11
(78.75%) |
0.4729
(0.5152) |
Clinical
fluid accumulation |
8 |
7
(87.5%) |
0.3607(0.8352) |
Lethargy/Restlessness |
8 |
4
(50%) |
0.4685
(0.5254) |
Table-4: Association of AST and ALT enzyme
levels with disease severity (n= 35)
|
Dengue without warning signs (n=14) |
Dengue with warning signs (n=16) |
Severe dengue (n=5) |
Total |
p value |
AST |
|||||
<2 fold rise |
2(14.28%) |
1(6.25%) |
0 |
3 |
0.723 |
Liver function
impairment (2-4 x ULN) |
7 (50%) |
8 (50%) |
2 (40%) |
17 |
|
Hepatitis (4-10x
ULN) |
3 (21.42%) |
5 (31.25%) |
2 (40%) |
10 |
|
Severe hepatitis
(>10 x ULN) |
2 (14.28%) |
2 (12.5%) |
1 (20%) |
5 |
|
ALT |
|||||
<2 fold rise |
10(71.42%) |
9(56.25%) |
2 (40%) |
21 |
0.196 |
Liver function
impairment (2-4x ULN) |
4 (28.57%) |
4 (25%) |
1 (20%) |
9 |
|
Hepatitis (4-10x
ULN) |
0 |
2 (18.75%) |
2 (40%) |
5 |
|
Severe hepatitis
(>10 x ULN) |
0 |
1(6.25%) |
0 |
0 |
Table-5: Comparison of indicators of hepatic
dysfunction with disease severity. (n= 35)
Indicator |
Dengue Without Warning Signs(n=14) |
Dengue With Warning Signs (n=16) |
Severe Dengue (n=5) |
p value |
Mean total bilirubin (mg/dl) |
0.65±0.34 |
0.69±0.53 |
0.38±0.11 |
0.3435 |
Mean ALT(U/L) |
67.85±34.99 |
120.38±112.01 |
134±104.61 |
0.1208 |
Mean AST(U/L) |
195.42±155.32 |
211.56±164.28 |
268.40±188.34 |
0.6479 |
Mean PT (Seconds) |
14.99±1.44 |
15.10±0.76 |
17.06±1.35 |
0.0056* |
Mean INR |
1.24±0.22 |
1.31±0.33 |
1.62±0.41 |
0.0623 |
*p< 0.05
Out of 35 cases with hepatic dysfunction, 2
had normal values of AST and ALT. While, 18 (51.42%) had elevated levels of
AST, 40% had elevation of AST and ALT both but none had elevation of ALT alone.
All patients with severe dengue had AST rise >2times the normal, whereas
92.9% and 87.5% of patients with dengue with warning signs and dengue without
warning signs had AST levels >2times the ULN respectively. 60% of cases with
severe dengue, 50% of dengue with warning signs and 25% of dengue without
warning signs had ALT levels >2 times the ULN. The mean levels of AST
increased with the severity of the disease. Although patients with hepatomegaly
had higher levels of liver enzymes (AST and ALT) than those without
hepatomegaly, this was not statistically significant. Mean PT was more in
severe dengue than in dengue with warning signs and dengue without warning
signs with statistically significant association (p<0.05). INR ≥1.5 was
noted in 8 patients, which is more in severe dengue than other groups. (Table 4)
(Table 5)
Discussion
Dengue fever (DF) is known to affect several
systems in the human body. Liver is the commonest organ to be involved in
dengue. Hepatic dysfunction is a well-recognized feature of dengue infection
and varying degree of dengue hepatitis is seen. The spectrum of involvement
includes asymptomatic elevation of hepatic transaminases to occurrence of
severe manifestation in form of acute liver cell failure (ALF)[5].
In our study 35 (67.30%) children with dengue
had one or the other hepatic manifestations (jaundice, hepatomegaly, raised
serum tranaminases and/or INR>1.5). Selvanet al observed hepatic dysfunction
in 30.6%[4]. Hepatic dysfunction in our study was observed in 64.70% of males
and 72.22% of female children with dengue. This observation was not
statistically significant. In children aged 2 months to 12 months with dengue, 85.71% had hepatic dysfunction.
Though not statically significant, this observation could be due to increased
vulnerability of liver cells to various insults during infancy. Prevalence of
hepatic dysfunction increases with severity of dengue infection. As observed in
our study, 80% and 83.3% of children who had dengue with warning signs and
severe dengue had hepatic dysfunction respectively.
Jaundice in our study was reported in only
one case, while in other studies incidence of jaundice ranges from 0-27.5% [4,13,14].
Hepatomegaly is an important clinical sign observed in our study seen. Total of
21(40.38%) children with hepatic dysfunction had hepatomegaly. All the patients
(100%) with severe dengue had hepatomegaly, which is statistically significant
(p=0.0262) when compared to less severe forms of dengue infection. Jagadishkumaret
al reported 21% of cases of dengue fever (DF) and 48% of dengue hemorrhagic
fever (DHF) cases had hepatomegaly [13]. Wahid et al observed a slightly higher
incidence of hepatomegaly in DHF (60%) group compared to DF (40%) group in
their study [7]. A study by Tambolkaret al observed hepatomegaly in 69% with
dengue fever and 100% with severe Dengue [15]. Thesefindings suggest that
hepatomegaly may be used as a predictor for assessing the hepatic dysfunction
in severe forms of dengue.
Ascites was seen in 8(15.38%) patients in our
study. In a study by Selvanet al 35.6% had ascites while Singh et alreported
ascites in 23% cases [4,16].In our study none of the patients had hepatic
encephalopathy or acute liver failure. While Selvanet alreported that 4.5% of
their cases had hepatic encephalopathy [4].
Mean AST and ALT levels were more in severe
dengue (268.40±188.34U/L and 134±104.61U/L) than DF with warning signsand DF
without warning signs. But this observation was not statistically
significant.26.92% and 61.53% of patients had ALT and AST rise more than 2
folds respectively. In a study by Jagadish kumar et al, mean AST and ALT levels
increased with severity of the disease and rise of enzymes were more in dengue
shock syndrome (DSS) and dengue hemorrhagic fever (DHF) compared to DF [13]. A
similar findings was noted by Tambolkar S A et al [15].
We found more than 10 fold rise in AST in 20%
of severe dengue, 12.5% of DF with warning signs and 14.28% of DF without
warning signs. Only in 6.25% of DF with warning signs there was elevation of
ALT more than 10 folds. JagadishKumaret alreported more than 10 fold rise of
AST in 44% of DSS, 22.8% of DHF and 3.4% of DFcases [13]. Tenfold rise of ALT
was noted in 16% of DSS, 7.7% of DHF and 0% of DF.
This indicates that severity of hepatitis
dysfunction is proportional to the severity of dengue infection. Elevation of
AST was more compared to ALT in the present study and similar observations was
made by others also [4,8,13,16]. AST rise more than ALT in dengue, probably due
to multi-organ affection in dengue, hence other sources of AST contributes to
its rise (erythrocytes, cardiac, skeletal, renal, brain). This differs from
pattern seen in viral hepatitis, in which ALT levels are usually more than or
equal to AST levels.
There was no significant difference in mean
TSB levels between disease groups. Only one patient of dengue with warning
signs had TSB of 2.4mg/dl. Singh et al observed mean TSB in severe dengue to be
significantly more compared to DF with warning signs and without warning signs
[16].
Bleeding manifestations are an important
clinical feature in DF. Mostly it is due to the low platelet count seen in
these patients. But a significant proportion of bleeding manifestations are due
to the presence of coagulopathy associated with DF. In our study bleeding in
the form of hemetemesis, epistaxis, malena were reported among 30.76% of cases.
Mean PT was more in severe dengue group compared to DF with or without warning
signs with statistical significance (pvalue-0.0056). INR >1.5 were found in
8(15.38%), more with severe dengue. In a study by Singhet al the PT/INR was deranged
in 11.11% patients [16]. In severe dengue and dengue fever with warning sign
groups, deranged PT/INR were 54.54% and 4.34% respectively. Similar findings
were noted by JagadishKumaret al [13].Derangementof coagulation profile as a
result of hepatic dysfunction increases with severity of disease contributing
to increased bleeding manifestations observed in these patients.
Conclusion
The prevalence of hepatic dysfunction among
children aged 2months- 12 years with dengue fever is 67.30%. This is more among
severe dengue than with less severe forms. Spectrum of hepatic involvement
varies from anicteric raised liver enzymes to clinically evident jaundice.
Hepatomegaly was the most important clinical sign seen in 40.38%. AST was more
commonly elevated than ALT in severe forms of dengue. Hepatic dysfunction was
more common in children with abdominal pain and clinical fluid accumulation.Derangement
of coagulation profile increased with severity of the disease. Thus, in
resource limited settings presence of warning signs like abdominal pain or
clinical fluid accumulation and severe forms of dengue should arouse the
suspicion of hepatic dysfunction as dengue hepatitis is primarily anicteric.
What
is already known?
Liver is the commonest organ to be involved
in dengue. Hepatic dysfunction is a well-recognized feature of dengue infection
and varying degree of dengue hepatitis is seen.
What
this study add to existing knowledge?
In resource limited settings presence of
warning signs like abdominal pain or clinical fluid accumulation and severe
forms of dengue should arouse the suspicion of hepatic dysfunction as dengue
hepatitis is primarily anicteric.
Contributions
by authors
(1) First author:
The conception and design of the study, drafting the article and final approval
of the version to be submitted.
(2) Second author:
Acquisition of data, analysis and interpretation of data.
(3) Corresponding author: Statistical analysis, revising for important intellectual content and correspondence.
Acknowledgements
Declarations
Funding:None
Conflict of Interest:None declared
Ethical approval:Not required
References
How to cite this article?
Siddappa F.D, Varsha Lakshman, Madhu P.K. Prevalence of hepatic dysfunction in children with dengue fever. Int J Pediatr Res. 2019;6(01):8-16.doi:10.17511/ijpr.2019.i01.02